Home › Funds › Manatuck Hill Partners, LLC › TOI
Manatuck Hill Partners, LLC position in TOI
STARLING ONCOLOGY INC COM
Manatuck Hill Partners, LLC reported holding 450,000 shares of TOI (STARLING ONCOLOGY INC COM) in its Q2 2026 13F filing — a position valued at US$2.4M, representing 0.81% of its reported portfolio and ranking #41 among its reported holdings. Manatuck Hill Partners, LLC has disclosed TOI holdings in 4 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Manatuck Hill Partners, LLC's TOI position evolved
Manatuck Hill Partners, LLC first disclosed a stake in TOI in Q1 2025 at 350,000 shares (US$399K). The position peaked in Q2 2026 at 450,000 shares, worth US$2.4M. Across 4 filings, Manatuck Hill Partners, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 450,000 shares valued at US$2.4M. Notable position changes include a 29% trim in Q2 2025, a 152% increase in Q3 2025.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 350.00K | $399.00K | New |
| Q2 2025 | 249.80K | $512.09K | Reduce |
| Q3 2025 | 629.80K | $2.20M | Add |
| Q2 2026 | 450.00K | $2.44M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TOI and 13F data
TOI (STARLING ONCOLOGY INC COM) is a company whose sector is not yet classified in our data. 64 other funds we track also report a position in TOI — the largest reported positions include JOSH ARNOLD INVESTMENT CONSULTANT, LLC (US$13.4M), WEXFORD CAPITAL LP (US$9.3M), BRC Group Holdings, Inc. (US$4.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TOI
- JOSH ARNOLD INVESTMENT CONSULTANT, LLC 2.46M sh · $13.38M · Q2 2026
- WEXFORD CAPITAL LP 1.71M sh · $9.29M · Q2 2026
- BRC Group Holdings, Inc. 742.59K sh · $4.03M · Q2 2026
- FourWorld Capital Management LLC 499.20K sh · $2.71M · Q2 2026
- Dauntless Investment Group, LLC 163.57K sh · $888.18K · Q2 2026
- Panoramic Capital, LLC 100.00K sh · $543.00K · Q2 2026
- T3 Companies, LLC 64.50K sh · $407.64K · Q3 2026
More on Manatuck Hill Partners, LLC
FAQ
How long has Manatuck Hill Partners, LLC held TOI?
Manatuck Hill Partners, LLC has disclosed TOI holdings in 4 of the last 6 reported quarters, going back to Q1 2025.
What is Manatuck Hill Partners, LLC's current position in TOI?
As of Q2 2026, Manatuck Hill Partners, LLC holds 450.00K shares of TOI (STARLING ONCOLOGY INC COM), valued at $2.44M, representing 0.81% of its reported portfolio and ranking #41.
Has Manatuck Hill Partners, LLC been buying or selling TOI?
In the latest 13F filing (Q2 2026), Manatuck Hill Partners, LLC newly opened its position in TOI. The position peaked in Q2 2026 at 450.00K shares.
Which other funds hold TOI?
Other major institutional holders of TOI include JOSH ARNOLD INVESTMENT CONSULTANT, LLC, WEXFORD CAPITAL LP, BRC Group Holdings, Inc., among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.